2011 - PhD in Internal Medicine: Zhejiang University
2015 - Zheng Yu Tung Doctoral Scholarship: University of Hong Kong
2016 - Research on Fatty Liver Disease Mechanism: Stanford University
2018 - Shandong Medical Science and Technology Award Second Prize (1/7)
2017 - Shandong Science and Technology Progress Award Second Prize (3/8)
2018 - Shandong Higher Education Science and Technology Award First Prize (4/8)
2019 - Huaxia Medical Science and Technology Award Third Prize (3/9)
2023 - Jiangsu Medical Science and Technology Award Second Prize (1/9)
Research
Fatty Liver Disease Viral Hepatitis
Prevalence, Incidence, and Outcome of Non-alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-analysis, Jie Li, Biyao Zou, Yee Hui Yeo, Yuemin Feng, Xiaoyu Xie, Dong Hyun Lee, Hideki Fujii, Yuankai Wu, Leslie Y. Kam, Fanpu Ji, Xiaohe Li, Nicholas Chien, Mike Wei, Eiichi Ogawa, Changqing Zhao, Xia Wu, Christopher D. Stave, Linda Henry, Scott Barnett, Hirokazu Takahashi, Norihiro Furusyo, Yuichiro Eguchi, Yao-Chun Hsu, Teng-Yu Lee, Wanhua Ren, Chengyong Qin, Dae Won Jun, Hidenori Toyoda, Vincent Wai-Sun Wong, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen, 2019
Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes, Jie Li, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, Yee NTS, Liu C, Nerurkar SN, Kai JCY, Teng MLP, Li X, Zeng H, Borghi JA, Henry L, Cheung R, Nguyen MH, 2021
Longitudinal proteomic investigation of COVID-19 vaccination, Yingrui Wang, Qianru Zhu, Rui Sun, Xiao Yi, Lingling Huang, Yifan Hu, Weigang Ge, Huanhuan Gao, Xinfu Ye, Yu Song, Li Shao, Yantao Li, Jie Li, Tiannan Guo, Junping Shi, 2023
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study, Fajuan Rui, Yee Hui Yeo, Liang Xu, Qi Zheng, Xiaoming Xu, Wenjing Ni, Youwen Tan, Qing-lei Zeng, Zebao He, Xiaorong Tian, Qi Xue, Yuanwang Qiu, Chuanwu Zhu, Weimao Ding, Jian Wang, Rui Huang, Yayun Xu, Yunliang Chen, Junqing Fan, Zhiwen Fan, Xiaolong Qi, Daniel Q. Huang, Qing Xie, Junping Shi, Chao Wu, Jie Li, 2023
Phosphatidic acid-enabled MKL1 contributes to liver regeneration: Translational implication in liver failure, Jiawen Zhou, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Zhiwen Fa, Jie Li, Yong Xua, Zilong Li, 2023
Alcohol Intake Thresholds in Individuals with Steatotic Liver Disease, Yee Hui Yeo, Yixuan Zhu, Juan Pablo Arab, Wenjing Ni, Xiaoming Xu, Junping Shi, Jie Li, 2023
The Presence of Baseline HBsAb-Specific B Cells Can Predict HBsAg or HBeAg seroconversion of Chronic Hepatitis B on treatment, Yin S, Wan Y, Issa R, Zhu Y, Xu X, Liu J, Mao M, Li M, Tong X, Tian C, Wang J, Huang R, Zhang Q, Wu C, Chen Y, Jie Li, 2023
The Changing Epidemiology of Liver Disease Among United States Children and Adolescents from 1999-2016, Jie Li, Michael H. Le, Monique T. Barakat, Ramsey C. Cheung, Mindie H. Nguyen, 2021
Nonalcoholic Fatty Liver Disease in Children: where are we?, Jie Li, Ramsey C. Cheung, 2022
Chronic Hepatitis B and Steatotic Liver Disease: a Blessing in Disguise?, Xiaoming Xu, Mindie H Nguyen, Jie Li, 2024
Comment on Cai et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020; 43:1392-1398 (Letter), Zebaohe, Jie Li, 2020
Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is Fat All Bad?, Jie Li, Ramsey C. Cheung, Mindie H. Nguyen, 2020
Screening for fatty liver disease and fibrosis in the elderly population: A call for action, Jie Li, Mindie H. Nguyen, 2023
Chronic hepatitis B and fatty liver-weal or woe?, Jie Li, Mindie H. Nguyen, 2022
A Promising Digital Therapeutics for Nonalcoholic Steatohepatitis: More Efforts Are Needed, Run Zhou, Binbin Zhang, Yunpeng Gu, Jie Li, Junping Shi, 2023
Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to interferon alpha, Jie Li, Feng Chen, Min Zheng, Haihong Zhu, Dongjiu Zhao, Weixia Liu, Wei Liu, Chen zhi, 2010
Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4, Yin S, Wang J, Chen L, Mao M, Rahma I, Geng Y, Huang R, Tong X, Liu Y, Wu C, Chen Y, Jie Li, 2023
C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease, Zhiwen Fan, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Yong Xu, Jie Li, Xiaoping Zou, Zilong Li, 2023
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021, Jie Li, Ha Audrey, Rui Fajuan, Zou Biyao, Yang Hongli, Xue Qi, Hu Xinyu, Xu Yayun, Henry Linda, Barakhat Monique, Stave Christopher, Shi Jun-Ping, Wu Chao, Cheung Ramsey, Mindie H. Nguyen, 2022
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary, Xu X, Liu J, Wu C, Jie Li, 2023
Fatty liver is not independently associated with rates of complete response to oral antiviral therapy in chronic hepatitis B patients, Jie Li, An K. Le, Kevin T. Chaung, Linda Henry, Joseph K. Hoang, Ramsey Cheung, Mindie H. Nguyen, 2020
The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection, Jie Li, Lung Yi Mak, Danny Wong, James Y. Y. Fung, Wai-Kay Seto, Ching Lung Lai, Man Fung Yuen, 2017
Non-alcoholic fatty liver disease (NAFLD) in Asia-More efforts are needed, Jie Li, Mindie H. Nguyen, 2020
Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD), Jie Li, Mindie H. Nguyen, 2021
Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B, Jie Li, Hwai-I Yang, Ming-Lun Yeh, An K. Le, Yee Hui Yeo, Chia-Yen Dai, Scott Barnett, Jian Q. Zhang, Jee-Fu Huang, Huy N. Trinh, Christopher Wong, Clifford Wong, Joseph K. Hoang, Ramsey Cheung, Ming-Lung Yu, Mindie H. Nguyen, 2021
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in diabetes patients, Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li, 2023
Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD), Shao L, Liu J, Song Y, Yang W, Gong L, Lyu Z, Zhu Q, Fu J, Jie Li, Shi J, 2023
Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease, Xin Tong, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Jun ping Shi, Jie Li, 2022
Diagnosis and assessment of disease severity in patients with Nonalcoholic Fatty Liver Disease, Jie Li, Adèle Delamarre, Vincent Wai-Sun Wong, Victor de Lédinghen, 2023
Clinical characteristics and possible etiology in children with acute severe hepatitis of unknown etiology, Jie Li, Xinyu Hu, Xuein Yan, Wu C, Yuemin Nan, 2022
Interaction between the Mucus Layer and the Gut Microbiota in NAFLD: Soil and Seeds, Binbin Zhang, Jie Li, Jinlong Fu, Luping Yang, Junping Shi, 2023
HBcAg induces Interleukin 10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients, Jie Li, Wei Wu, Guoping Peng, Feng Chen, Minghui Bai, Min Zheng and Zhi Chen, 2010
Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase, Zhan J, Wang J, Zhang Z, Xue R, Jiang S, Liu J, Liu Y, Zhu L, Xia J, Yan X, Ding W, Zhu C, Qiu Y, Jie Li, Huang R, Wu C, 2023
Characteristics and mechanism of liver injury in 2019
